Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Screening and surveillance for asymptomatic colorectal cancer in IBD.

Forbes A, Gabe S, Lennard-Jones JE, Wilkinson K.

Gut. 2003 May;52(5):769; author reply 769-70. No abstract available.

2.

Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6.

Fisher SA, Hampe J, Macpherson AJ, Forbes A, Lennard-Jones JE, Schreiber S, Curran ME, Mathew CG, Lewis CM.

Eur J Hum Genet. 2002 Apr;10(4):259-65.

3.

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG.

Lancet. 2001 Jun 16;357(9272):1925-8. Erratum in: Lancet 2002 Sep 7;360(9335):806.

PMID:
11425413
4.

Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Witte J, Shivananda S, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi A, Tsianos EV, Mouzas I, Schulz TB, Monteiro E, Clofent J, Odes S, Limonard CB, Stockbrügger RW, Russel MG.

Scand J Gastroenterol. 2000 Dec;35(12):1272-7.

PMID:
11199366
5.

Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease.

Hampe J, Lynch NJ, Daniels S, Bridger S, Macpherson AJ, Stokkers P, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S.

Gut. 2001 Feb;48(2):191-7.

6.

Ethical and legal aspects of clinical hydration and nutritional support.

Lennard-Jones JE.

BJU Int. 2000 Mar;85(4):398-403. Review. No abstract available.

7.

Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease.

Olavesen MG, Hampe J, Mirza MM, Saiz R, Lewis CM, Bridger S, Teare D, Easton DF, Herrmann T, Scott G, Hirst J, Sanderson J, Hodgson SV, Lee J, MacPherson A, Schreiber S, Lennard-Jones JE, Curran ME, Mathew CG.

Immunogenetics. 2000 Jan;51(1):1-7.

PMID:
10663555
8.

Ulcerative colitis is not associated with differences in MUC2 mucin allele length.

Swallow DM, Vinall LE, Gum JR, Kim YS, Yang H, Rotter JI, Mirza M, Lee JC, Lennard-Jones JE.

J Med Genet. 1999 Nov;36(11):859-60. No abstract available.

9.

Linkage of inflammatory bowel disease to human chromosome 6p.

Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S.

Am J Hum Genet. 1999 Dec;65(6):1647-55.

10.

Giving or withholding fluid and nutrients: ethical and legal aspects.

Lennard-Jones JE.

J R Coll Physicians Lond. 1999 Jan-Feb;33(1):39-45. Review.

PMID:
10192069
11.

A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.

Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Buckler A, Hall J, Stokkers P, van Deventer SJ, Nürnberg P, Mirza MM, Lee JC, Lennard-Jones JE, Mathew CG, Curran ME.

Am J Hum Genet. 1999 Mar;64(3):808-16.

12.

Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells.

Lee JC, Cevallos AM, Naeem A, Lennard-Jones JE, Farthing MJ.

Gut. 1999 Feb;44(2):196-202.

13.

Ethical and legal aspects of nutrition and hydration.

Lennard-Jones JE.

Nurs Stand. 1998 Sep 30-Oct 6;13(2):33.

PMID:
9847755
14.

Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation.

van der Sijp JR, Kamm MA, Nightingale JM, Akkermans LM, Ghatei MA, Bloom SR, Jansen JB, Lennard-Jones JE.

Am J Gastroenterol. 1998 Aug;93(8):1351-6.

PMID:
9707064
15.

Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis.

Mirza MM, Lee J, Teare D, Hugot JP, Laurent-Puig P, Colombel JF, Hodgson SV, Thomas G, Easton DF, Lennard-Jones JE, Mathew CG.

J Med Genet. 1998 Mar;35(3):218-21.

16.
17.

The fascination of IBD.

Lennard-Jones JE.

Neth J Med. 1997 Feb;50(2):S28-30. No abstract available.

PMID:
9050331
18.

Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives.

Lee JC, Lennard-Jones JE.

Gastroenterology. 1996 Sep;111(3):587-96.

PMID:
8780561
19.

Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying.

Nightingale JM, Kamm MA, van der Sijp JR, Ghatei MA, Bloom SR, Lennard-Jones JE.

Gut. 1996 Aug;39(2):267-72.

20.
21.

HLA and inflammatory bowel disease.

Mathew CG, Easton DF, Lennard-Jones JE.

Lancet. 1996 Jul 6;348(9019):68. No abstract available.

PMID:
8691965
22.

Defining ulcer depth in colitis.

Lennard-Jones JE.

Lancet. 1996 Jun 22;347(9017):1708. No abstract available.

PMID:
8656898
23.

Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G.

Nature. 1996 Feb 29;379(6568):821-3.

PMID:
8587604
24.

Screening by nurses and junior doctors to detect malnutrition when patients are first assessed in hospital.

Lennard-Jones JE, Arrowsmith H, Davison C, Denham AF, Micklewright A.

Clin Nutr. 1995 Dec;14(6):336-40.

PMID:
16843954
25.

Adult patients with a short bowel due to Crohn's disease often start with a short normal bowel.

Nightingale JM, Lennard-Jones JE.

Eur J Gastroenterol Hepatol. 1995 Oct;7(10):989-91.

PMID:
8590147
26.

Colitic cancer: supervision, surveillance, or surgery?

Lennard-Jones JE.

Gastroenterology. 1995 Oct;109(4):1388-91. No abstract available.

PMID:
7557111
27.
28.

Is colonoscopic cancer surveillance in ulcerative colitis essential for every patient?

Lennard-Jones JE.

Eur J Cancer. 1995 Jul-Aug;31A(7-8):1178-82. Review.

PMID:
7577017
29.

Nutritional support in intensive care units in England and Wales: a survey.

Hill SA, Nielsen MS, Lennard-Jones JE.

Eur J Clin Nutr. 1995 May;49(5):371-8.

PMID:
7664724
30.

Fungal feeding-line infections: beware the eyes and teeth.

Nightingale JM, Simpson AJ, Towler HM, Lennard-Jones JE.

J R Soc Med. 1995 May;88(5):258-63.

31.

Antineutrophil antibodies in familial inflammatory bowel disease.

Lee JC, Lennard-Jones JE, Cambridge G.

Gastroenterology. 1995 Feb;108(2):428-33.

PMID:
7835584
32.

Review article: practical management of the short bowel.

Lennard-Jones JE.

Aliment Pharmacol Ther. 1994 Dec;8(6):563-77. Review.

PMID:
7696444
33.

Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis.

Gertner DJ, Rampton DS, Madden MV, Talbot IC, Nicholls RJ, Lennard-Jones JE.

Gut. 1994 Oct;35(10):1429-32.

34.

Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.

Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, Lennard-Jones JE.

Gut. 1994 Oct;35(10):1419-23.

35.

Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH.

Gastroenterology. 1994 Oct;107(4):934-44.

PMID:
7926483
36.

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE.

Lancet. 1994 May 21;343(8908):1249-52.

PMID:
7910274
37.

Lower gastrointestinal malignancy in Crohn's disease.

Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE.

Gut. 1994 Mar;35(3):347-52. Review.

38.

Clinical management of constipation.

Lennard-Jones JE.

Pharmacology. 1993 Oct;47 Suppl 1:216-23. Review.

PMID:
8234432
39.

Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'.

Nightingale JM, Kamm MA, van der Sijp JR, Morris GP, Walker ER, Mather SJ, Britton KE, Lennard-Jones JE.

Gut. 1993 Sep;34(9):1171-6.

40.

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE.

Gut. 1993 Aug;34(8):1081-5.

41.

Disturbed gastric and small bowel transit in severe idiopathic constipation.

van der Sijp JR, Kamm MA, Nightingale JM, Britton KE, Granowska M, Mather SJ, Akkermans LM, Lennard-Jones JE.

Dig Dis Sci. 1993 May;38(5):837-44.

PMID:
8482182
42.

Evolution of the controlled clinical trial.

Lennard-Jones JE.

Mt Sinai J Med. 1993 May;60(3):180-5. No abstract available.

PMID:
8345845
43.

Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers.

van der Sijp JR, Kamm MA, Nightingale JM, Britton KE, Mather SJ, Morris GP, Akkermans LM, Lennard-Jones JE.

Gut. 1993 Mar;34(3):402-8.

44.

The short bowel syndrome: what's new and old?

Nightingale JM, Lennard-Jones JE.

Dig Dis. 1993;11(1):12-31. Review.

PMID:
8443953
45.

Observations on the characteristics of stimulated defaecation in severe idiopathic constipation.

Kamm MA, van der Sijp JR, Lennard-Jones JE.

Int J Colorectal Dis. 1992 Dec;7(4):197-201.

PMID:
1293240
47.

An in vitro electrophysiological study of the colon from patients with idiopathic chronic constipation.

Hoyle CH, Kamm MA, Lennard-Jones JE, Burnstock G.

Clin Auton Res. 1992 Oct;2(5):327-33.

PMID:
1330123
48.

Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day.

Giaffer MH, Holdsworth CD, Lennard-Jones JE, Rodrigues CA, McIntyre PB, Manjunatha S, Baron JH, Barrison IG, Polson RJ, Hoare AM, et al.

Aliment Pharmacol Ther. 1992 Aug;6(4):479-85.

PMID:
1358234
49.

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Hawthorne AB, Logan RF, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET, Scott BB, Lennard-Jones JE.

BMJ. 1992 Jul 4;305(6844):20-2.

50.

Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.

O'Donnell LJ, Arvind AS, Hoang P, Cameron D, Talbot IC, Jewell DP, Lennard-Jones JE, Farthing MJ.

Gut. 1992 Jul;33(7):947-9.

Supplemental Content

Loading ...
Support Center